Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients

Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis

(2018) Massimo Milione et al.   ENDOCRINE-RELATED CANCER

Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer

(2018) Anna C. Wilkins et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma

(2018) Chen Zhou et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Frequency of circulating CD14++ CD16+ intermediate monocytes as potential biomarker for the diagnosis of oral squamous cell carcinoma

(2018) Yuxian Song et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy

(2018) Paula Cabrera‐Galeana et al.   ONCOLOGIST

Age- and localization-dependent functional and psychosocial impairments and health related quality of life six months after OSCC therapy

(2018) Sabine S. Linsen et al.   ORAL ONCOLOGY

Differences in Ki67 expressions between pre- and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer

(2017) Emi Tokuda et al.   HUMAN PATHOLOGY

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

(2016) Sara Bustreo et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Tumor Heterogeneity--A 'Contemporary Concept Founded on Historical Insights and Predictions

(2016) D. R. Welch   CANCER RESEARCH

Roles of FGFR in oral carcinogenesis

(2016) Xiaoyan Xie et al.   CELL PROLIFERATION

Partial Oxygen Pressure Affects the Expression of Prognostic Biomarkers HIF-1 Alpha, Ki67, and CK20 in the Microenvironment of Colorectal Cancer Tissue

(2016) Lirong Zhang et al.   Oxidative Medicine and Cellular Longevity

Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours

(2016) Claudio Ricci et al.   PANCREATOLOGY

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

(2015) A. S. Coates et al.   ANNALS OF ONCOLOGY

Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma

(2015) Yan Hong Ni et al.   HISTOPATHOLOGY

High Ki67 expression is an independent good prognostic marker in colorectal cancer

(2015) Nathaniel Melling et al.   JOURNAL OF CLINICAL PATHOLOGY

Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients

(2015) Yan-Hong Ni et al.   TUMOR BIOLOGY

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy

(2014) A. Sheri et al.   ANNALS OF ONCOLOGY

Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study

(2014) Ying Chen et al.   Diagnostic Pathology

Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies

(2014) Michelle D. Reid et al.   ENDOCRINE PATHOLOGY

Ki67 Index in Breast Cancer: Correlation with Other Prognostic Markers and Potential in Pakistani Patients

(2013) Saroona Haroon et al.   Asian Pacific Journal of Cancer Prevention

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

(2013) G. von Minckwitz et al.   CLINICAL CANCER RESEARCH

Influence of tumour micro-environment heterogeneity on therapeutic response

(2013) Melissa R. Junttila et al.   NATURE

Tumor and its microenvironment: A synergistic interplay

(2013) Veronica Catalano et al.   SEMINARS IN CANCER BIOLOGY

Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver

(2011) Zhaohai Yang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

(2011) Elisabeth Luporsi et al.   BREAST CANCER RESEARCH AND TREATMENT

Diagnostic utility of ki67 and p53 immunostaining on solitary thyroid nodule - A cytohistological and radionuclide scintigraphic study

(2011) Smita Singh et al.   Indian Journal of Pathology and Microbiology

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Breast Cancer Subtypes and the Risk of Local and Regional Relapse

(2010) K. David Voduc et al.   JOURNAL OF CLINICAL ONCOLOGY

The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

(2010) Roy M. Bremnes et al.   Journal of Thoracic Oncology

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Prognostic Significance of Ki-67 Labeling Index in Papillary Thyroid Carcinoma

(2010) Yasuhiro Ito et al.   WORLD JOURNAL OF SURGERY

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

(2009) D M Berney et al.   BRITISH JOURNAL OF CANCER